These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 21236244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
    Wood TK, McDermott KW, Sullivan AM.
    J Neurosci Res; 2005 Jun 15; 80(6):759-66. PubMed ID: 15880784
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.
    Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226
    [Abstract] [Full Text] [Related]

  • 9. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AC.
    J Comp Neurol; 1995 May 15; 355(4):479-89. PubMed ID: 7636027
    [Abstract] [Full Text] [Related]

  • 10. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 11. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.
    J Neurochem; 2004 May 18; 89(3):776-87. PubMed ID: 15086533
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 14. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C.
    Exp Neurol; 1993 Dec 24; 124(2):401-12. PubMed ID: 7904571
    [Abstract] [Full Text] [Related]

  • 15. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X, Hagg T.
    J Comp Neurol; 1997 Nov 24; 388(3):484-94. PubMed ID: 9368855
    [Abstract] [Full Text] [Related]

  • 16. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C, Papazoglou A, Just L, Nikkhah G.
    Exp Cell Res; 2010 Mar 10; 316(5):737-46. PubMed ID: 20060824
    [Abstract] [Full Text] [Related]

  • 18. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA, Su C.
    Exp Neurol; 2002 Apr 10; 174(2):230-42. PubMed ID: 11922664
    [Abstract] [Full Text] [Related]

  • 19. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.
    J Pharm Pharmacol; 2004 May 10; 56(5):649-54. PubMed ID: 15142343
    [Abstract] [Full Text] [Related]

  • 20. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.
    Zhang L, Fletcher-Turner A, Marchionni MA, Apparsundaram S, Lundgren KH, Yurek DM, Seroogy KB.
    J Neurochem; 2004 Dec 10; 91(6):1358-68. PubMed ID: 15584912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.